SCHEMBL1070337

SCHEMBL1070337

O=C=NCC1CC2CCC1C2

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
POLB P06746 2/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
HIF1A Q16665 1/20 0.31
HSD17B10 Q99714 1/20 0.31
P2RX7 Q99572 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2330759 0.87
SCHEMBL11253736 0.81 MEN1 (0.35) MEN1NPC1RAB9AKMT2APOLB
SCHEMBL13398596 0.80 MEN1 (0.33) MEN1NPC1RAB9AKMT2A
SCHEMBL16648870 0.78 MEN1 (0.33) MEN1NPC1RAB9AKMT2A
SCHEMBL16266139 0.78 ALDH1A1 (0.37)
SCHEMBL7193521 0.77
SCHEMBL19604115 0.77 MEN1 (0.40) MEN1NPC1RAB9AKMT2APOLB
SCHEMBL95678 0.76
SCHEMBL7184395 0.73
SCHEMBL22899096 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 523 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509547-B2 Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component BASF SE (DE) 2025-12-30 US claimed
US-20230348657-A1 SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT BASF SE (DE) 2023-11-02 US claimed
EP-4185626-A1 SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT BASF SE (DE) 2023-05-31 EP claimed
CN-116137864-A Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component 巴斯夫欧洲公司 2023-05-19 CN claimed
CN-112996835-B Method for producing thermoplastic polyoxazolidone polymers 科思创知识产权两合公司 2022-12-13 CN claimed
US-11427671-B2 Method for the production of thermoplastic polyoxazolidinone polymers COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2022-08-30 US claimed
EP-3873961-B1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-08-17 EP claimed
US-11370874-B2 Method for the production of thermoplastic polyoxazolidone polymers COVESTRO DEUTSCHLAND AG (DE) 2022-06-28 US claimed
EP-3873962-B1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-05-18 EP claimed
EP-3681924-B1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-05-18 EP claimed
CN-101466754-A Aqueous polyurethane resin MITSUI CHEMICALS POLYURETHANES (JP) 2009-06-24 CN claimed
CN-101165048-A Method for preparing polyisocyanic acid ester BAYER AG (DE) 2008-04-23 CN claimed
CN-1712423-A Polyurethane dispersions with high acid content BAYER MATERIALSCIENCE LLC (US) 2005-12-28 CN claimed
CN-1509301-A Process for preparing aliphatic polyisocyanates having uretdione, isocyanurate and iminooxadiazinedione structures 2004-06-30 CN claimed
CN-1509302-A Process for preparing polyisocyanates 2004-06-30 CN claimed
CN-1155841-C Plastic spectacle lens ������������ʽ���� 2004-06-30 CN claimed
CN-1140518-C Method for preparing polyisocyanate containing imidoyl-oxadiazine-diketone 2004-03-03 CN claimed
CN-1313513-A Plastic spectacle lens HOYA CORP (JP) 2001-09-19 CN claimed
CN-1243124-A Method for preparing polyisocyanate containing imidoyl-oxadiazine-diketone BAYER AG (DE) 2000-02-02 CN claimed
US-4918148-A IMPROVED FLOWABILITY, MOLD RELEASE AND-OR NOTCHED IMPACT STRENGTH BAYER AKTIENGESELLSCHAFT (DE) 1990-04-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509547-B2 Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component BMP1, BMP4, PBRM1 MEN1 250/4885NPC1 4211/4885RAB9A 3259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.